Abstract

Therapeutic interventions of hepatic ischemia-reperfusion injury to attenuate liver dysfunction or multiple organ failure following liver surgery and transplantation remain limited. Here we present an innovative strategy by integrating a platinum nanoantioxidant and inducible nitric oxide synthase into the zeolitic imidazolate framework-8 based hybrid nanoreactor for effective prevention of ischemia-reperfusion injury. We show that platinum nanoantioxidant can scavenge excessive reactive oxygen species at the injury site and meanwhile generate oxygen for subsequent synthesis of nitric oxide under the catalysis of nitric oxide synthase. We find that such cascade reaction successfully achieves dual protection for the liver through reactive oxygen species clearance and nitric oxide regulation, enabling reduction of oxidative stress, inhibition of macrophage activation and neutrophil recruitment, and ensuring suppression of proinflammatory cytokines. The current work establishes a proof of concept of multifunctional nanotherapeutics against ischemia-reperfusion injury, which may provide a promising intervention solution in clinical use.

Pharmacological interventions against hepatic ischemia-reperfusion injury remain limited. Here, the authors provide a nanotherapeutics-based solution combining reactive oxygen species scavenging and nitric oxide modulation.

Details

Title
Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury
Author
Mu Jing 1 ; Li, Chunxiao 2 ; Shi, Yu 1 ; Liu, Guoyong 1 ; Zou Jianhua 3 ; Dong-Yang, Zhang 4 ; Jiang, Chao 4 ; Wang, Xiuli 2 ; He Liangcan 5   VIAFID ORCID Logo  ; Huang, Peng 4   VIAFID ORCID Logo  ; Yin Yuxin 1   VIAFID ORCID Logo  ; Chen, Xiaoyuan 3   VIAFID ORCID Logo 

 Peking University Shenzhen Hospital, Institute of Precision Medicine, Shenzhen, China (GRID:grid.440601.7) (ISNI:0000 0004 1798 0578) 
 Tongji University, Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535) 
 National University of Singapore, Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
 Shenzhen University, Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Health Science Center, Shenzhen, China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649) 
 Harbin Institute of Technology, School of Medicine and Health, Harbin, China (GRID:grid.19373.3f) (ISNI:0000 0001 0193 3564) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2660203290
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.